Jim Wassil - Jun 10, 2022 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4
Date filed
6/14/2022, 05:10 PM
Previous filing
Apr 20, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $0 +11.1K $0.00 11.1K Jun 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +44.6K $0.00 44.6K Jun 10, 2022 Common Stock 44.6K $6.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on June 10, 2022. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of June 10, 2022, the vesting commencement date, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date. Vesting of the RSUs shall accelerate upon a Change of Control (as defined in the Icosavax, Inc. 2021 Incentive Award Plan). Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
F2 1/36th of the total number of shares of common stock subject to the option vest monthly following June 10, 2022, the vesting commencement date, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.